Three Recent Biotechnology Activist Wins by Carl Icahn
August 30, 2009 by mdbeckerpartners · Leave a Comment
Although a controversial topic, activist hedge funds and private equity firms typically use a small equity stake in an underperforming company to put public pressure on its management and board of directors with the goal of increasing stakeholder value through cost cutting, changes in corporate strategy or management, capital restructuring, asset divestiture and other tactics. [...]
Novel Diabetes Therapies Presented at 2009 ADA Meeting
June 23, 2009 by mdbeckerpartners · Leave a Comment
Approximately 250 million people worldwide have been diagnosed with diabetes mellitus and that number is growing with the increasing obesity population. Broadly, patients with diabetes are characterized by elevated blood glucose levels that result from either insufficient insulin secretion (type-1 diabetes) or ineffective insulin action (type-2 diabetes). The market for treating patients with diabetes is [...]
